Skip to main content
Equibles
AMCR logo

AMCR · Amcor plc

Track AMCR — free

Use AMCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$45.31 -0.53 (-1.16%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$21.19B
Shares
462.35M
Volume · Nov 6 1.11M Avg daily vol (3M) 3.54M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$45.84 Open$45.30 Day$44.70–46.46 52W close$36.69–50.58 Avg vol 30d3.5M Short int23.5M · 5.1% of shares · 7.9d Short vol65% Last earningsNov 4, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

Next earnings call
Feb 7, 2027 Est · unconfirmed · in 13 wks
Q3 2026 earnings call transcript
call held Nov 4, 2026
Play latest call

Latest documents

2026
Oct 28
Proxy statement DEFA14A
STI payout reached 52% of target

Amcor disclosed a 52% STI payout and approved Berry Global integration awards comprising approximately 70% PSUs and 30% Options. The Board recommends FOR Proposal Three on executive compensation.

5 source passages
As shown in the following table, which compares the actual performance outcomes relative to target for recent STI and LTI awards (including performance share units (“PSUs”) and share options (“Options”) subject to performance conditions) granted to Amcor executives, certain awards have either not been paid out or have paid out at below-target levels due to the rigor and aspirational nature of the performance goals set by the Compensation Committee. STI (average of NEO outcomes) | 112% | 21% | 56% | 49% | 52% In support of the integration of Berry Global, the Compensation Committee approved a one-time, transaction-based long-term incentive award to our Senior Executives and a select group of other key executives, including our NEOs, with direct responsibility for integration execution and delivery against the value creation commitments made to shareholders in connection with the Merger. These awards consist of PSUs and Options, representing approximately 70% and 30% of the total award value, respectively, each as described below. Consistent with its recommendation as disclosed in the Proxy Statement, the Board of Directors continues to recommend a vote “FOR” the approval of Proposal Three, the Advisory Vote on Executive Compensation. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$23.51B
Trailing 12 months
Net income (TTM)
$1.11B
Trailing 12 months
Revenue growth YoY
+25.9%
Year over year
Operating margin
8.1%
Trailing 12 months
P / E (TTM)
20.4
Trailing earnings · reciprocal yield 4.9%
FCF yield
5.5%
TTM · current market cap
Return on invested capital
6.6%
Trailing 12 months
Net cash
−$12.90B
Latest balance sheet
Dividend yield
5.4%
Trailing 12 months
Shares change YoY
+60.4%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
5.1%
Latest settlement · 7.9 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▼2.6% $3.35B $191.00M '25 Q1 ▼0.3% $3.24B $163.00M '25 Q2 ▼2.3% $3.33B $196.00M '25 Q3 ▲43.8% $5.08B −$39.00M '25 Q4 ▲71.3% $5.75B $262.00M '26 Q1 ▲68.1% $5.45B $177.00M '26 Q2 ▲77.4% $5.91B $278.00M '26 Q3 LATEST ▲25.9% $6.40B $389.00M '26 Q4*

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q2 FY26 earnings call · Aug 12, 2026
Q2 FY26

TL;DR. AMCR delivered strong FY26 results with adjusted EPS up 13% to $4.02 and Q4 adjusted EPS up 23% to $1.23, driven by Berry synergies that beat plan. For the six-month transition period, the company guided adjusted EPS of $1.80–$1.90, and signaled double-digit adjusted EPS growth and ~3x leverage by year-end 2027.

Bullish
  • + FY26 adjusted EPS rose 13% to $4.02, meeting double-digit growth target. new
  • + Berry synergies reached $285M in FY26, ~$10M ahead of initial year-one target. new
  • + Volumes inflected to modestly positive in Q4 with ~200bps sequential improvement across categories. new
  • + Company guided to double-digit adjusted EPS growth in calendar 2027 with leverage to ~3x. new
  • + Quarterly dividend raised modestly to $0.65/share, continuing annual dividend growth. new
Bearish
  • − FY26 free cash flow of $1.3B was $200M below the outlook range due to Middle East conflict working capital impacts. new
  • − Higher interest and tax represent a $0.10–$0.12 unfavorable drag to EPS in the transition period. new
  • − Healthcare volumes remain weak due to softness in lower-margin subcategories. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 28.2 · fear Equity put/call 0.89
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +6%
above
Price vs 50-day avg +4%
above
RSI (14) 53
neutral
MACD trend Positive
52-week position 66%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +9%
trailing
6-month return +25%
trailing
YTD return +10%
this year
Relative strength +26%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $44 › 200d $43 — 50d above 200d
Institutional flow Distributing
365 of 715 funds reported for Sep 30 · net -1.4M sh shares · +46 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.08% of shares out · ▲ +8.8% MoM · 7.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
715 holders — mid 3-yr range
Squeeze score 85
high risk · 0–100
Fundamentals
Excellent
Revenue growth +9%
Y/Y
Gross margin 34%
expanding
EPS growth +49%
Y/Y
Free cash flow $1.8B
Valuation P/E 19.3
below peers
Buyback $321.0M
remaining
Balance sheet $12.9B
net debt
Quant / Vol
risk profile
Moderate
Volatility 32%
annualized · 1-yr
Max drawdown −27%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 12, 2026
Adjusted Diluted EPS · Six Months Ended December 31, 2026 ('Transition Period') Non-GAAP $1.80 – $1.90
Previous outlook earlier release · from the Earnings Call filed May 6, 2026

Still-open targets the latest release did not restate under the same label.

Adjusted EPS · fiscal year 2026 $3.98 – $4.03
Free cash flow · fiscal 2026 $1.5B – $1.6B
Capital spending · fiscal 2026 $850M – $900M
Synergies · year one $270M
Synergies · year two $260M
Synergies (total) · three years $650M
Growth synergies · three years $280M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+6% Bullish
Price vs 50-day avg
+4% Bullish
RSI (14)
53 Neutral
MACD trend
Positive Bullish
52-week position
66% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $44 › 200d $43 — 50d above 200d
Institutional flow Distributing
365 of 715 funds reported for Sep 30 · net -1.4M sh shares · +46 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
5.08% of shares out · ▲ +8.8% MoM · 7.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
715 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $37 Now $46 · 66% Range high $51
vs 200-day avg +6% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted net income non-GAAP $1.86B fiscal year 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Adjusted EBIT $2.81B
-$676M Interest expense
+$29M Adjustments to interest expense
-$181M Income tax expense
-$188M Adjustments to income tax expense
+$66M Interest income
+$0M Net income attributable to non-controlling interests
= Adjusted net income $1.86B
Adjusted Segment EBIT non-GAAP $2.97B fiscal 2026 filing —
Share options outstanding 8.6M fiscal year 2026 filing —
Adjusted Diluted EPS non-GAAP $4.02 Fiscal Year Ended June 30, 2026 —
Adjusted EBITDA non-GAAP $3.67B Fiscal Year Ended June 30, 2026 —
Adjusted Free Cash Flow non-GAAP $1.59B Twelve Months Ended June 30, 2026 —
approximately 400 locations 400 Fiscal Year Ended June 30, 2026 —
approximately 75,000 Amcor people 75,000 Fiscal Year Ended June 30, 2026 —
Free Cash Flow non-GAAP $1.3B Twelve Months Ended June 30, 2026 —
Net debt non-GAAP $12.9B June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaging & Containers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AMCR
Amcor plc
this stock
$21.19B — +56.6% 19.3 5.1%
SW
Smurfit Westrock plc
 $23.35B +15.1% +47.7% 50.0 4.4%
PKG
Packaging Corp Of America
 $22.58B +20.6% +7.2% 31.2 3.6%
IP
International Paper Co
 $18.13B -13.1% +49.3% — 0.0%
BALL
BALL Corp
 $17.42B +26.3% +11.6% 34.0 3.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
740
% held
78.3%
Reported
365 of 715
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
202
View
Short & Settlement
Short Interest Rising
Shares short
23.5M
Days to cover
7.9d
Change
+1.9M sh
View
Short Volume
Short vol %
65%
As of
Nov 5, 2026
Short Total
View
Fails to Deliver
FTD shares
22
Value
$934
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
35.7%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Thomas H. Kean
Amount
$1.0K–$15.0K
Traded
Aug 10, 2026
View
Financials
Financials
Revenue (FY)
$23.5B
Net income (FY)
$1.1B
EPS diluted
$2.38
View
Buybacks
Remaining
$321.0M
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 5, 2026
This year
19
View
Proposed Sales
Value
$1.4M
Shares
30.0K
Filed
Feb 6, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 4, 2026
View
Investor Relations
Latest news
Amcor to report September 2026 re…
Published
Oct 22, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
AMCR -2.7% +9.5% +24.9% -3.3% +9.9%
SPY -4.7% -5.3% -0.8% -3.0% +7.5%
vs SPY +2.0% +14.8% +25.8% -0.3% +2.4%

Capital returns

Latest dividend
$0.65 / share · ex Sep 4, 2026
Declared · upcoming
$0.66 / share · ex Nov 25, 2026
Raised 1.6%
Paid (TTM)
$2.60 / share · 4 payouts
Dividend yield (TTM, derived)
5.67%
Full dividend history
Buyback program · as of Sep 28, 2024
Authorized
—
Spent (derived)
—
Remaining
$321.00M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1748790 CUSIP G0250X149 13F (30d) 379 filings 337 filers Visit website Investor relations